| Value | ₹130.0 Cr |
|---|
BSE filing, NSE: MODINSULAT. Summary written from the filing by ALFA Finder's alert engine.
Modern Insulators Ltd: key numbers
- Share price
- ₹434.15
- Market cap
- ₹2,047 Cr
- Revenue (annual)
- ₹719.8 Cr
- Net profit (annual)
- ₹79.78 Cr
- P/E (TTM)
- 21.7×Sector 41.2×
- Promoter holding
- 60.18%+0.00% QoQ
- FII holding
- 0.31%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Modern Insulators Ltd
All →Modern Insulators Other Announcement
Modern Insulators Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations. This is a routine compliance disclosure.
Modern Insulators Annual General Meeting
Modern Insulators Ltd held its 41st AGM on September 30, 2026. Shareholders considered the adoption of FY26 financial statements and director reappointments.
Modern Insulators Annual General Meeting
Modern Insulators Limited has submitted its Annual Report for the financial year ended March 31, 2026, and the notice for its 41st Annual General Meeting.
Modern Insulators Credit Rating
Modern Insulators received a credit rating update from CRISIL, with total bank loan facilities rated at ₹165 Crore and existing ratings reaffirmed.
Modern Insulators Q1 FY27 Results: Net Profit ₹29.6 Cr, Up 94.7% YoY
Modern Insulators Ltd reported revenue from operations of ₹188.3 Cr (+33.2% YoY) and net profit of ₹29.6 Cr (+94.7% YoY) for Q1 FY27.
- Key figure
- Net profit ₹29.6 Cr · +94.7% YoY
Modern Insulators Board Meeting Date
Modern Insulators Ltd has scheduled a board meeting for August 10, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.